Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MGPI | Common Stock | Sale | -$680K | -5.9K | -0.91% | $115.32 | 645K | Sep 6, 2023 | By Trusts | F1, F5 |
transaction | MGPI | Common Stock | Sale | -$58K | -500 | -0.08% | $116.02 | 645K | Sep 6, 2023 | By Trusts | F2, F5 |
transaction | MGPI | Common Stock | Sale | -$11.7K | -100 | -0.02% | $116.82 | 645K | Sep 6, 2023 | By Trusts | F5 |
transaction | MGPI | Common Stock | Sale | -$592K | -5.2K | -0.81% | $113.78 | 639K | Sep 7, 2023 | By Trusts | F3, F5 |
transaction | MGPI | Common Stock | Sale | -$137K | -1.2K | -0.19% | $114.52 | 638K | Sep 7, 2023 | By Trusts | F4, F5 |
transaction | MGPI | Common Stock | Sale | -$11.6K | -100 | -0.02% | $115.63 | 638K | Sep 7, 2023 | By Trusts | F5 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.750 to $115.730, inclusive. The reporting person undertakes to provide to MGP Ingredients Inc. (MGPI), any security holder of MGPI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) to this Form 4. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.790 to $116.560, inclusive. The reporting person undertakes to provide to MGP Ingredients Inc. (MGPI), any security holder of MGPI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) to this Form 4. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.340 to $114.320, inclusive. The reporting person undertakes to provide to MGP Ingredients Inc. (MGPI), any security holder of MGPI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (3) to this Form 4. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.360 to $114.920, inclusive. The reporting person undertakes to provide to MGP Ingredients Inc. (MGPI), any security holder of MGPI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (4) to this Form 4. |
F5 | The shares in this transaction were sold by the CNL 2013 Irrevocable Trust dated April 2, 2013 ("CNL Trust"), of which Catherine Lux is a co-trustee. Catherine Lux also shares voting power as co-trustee of the Ann S. Lux 2005 Irrevocable Trust FBO Catherine N. Lux dated 9/16/2005 ("Lux 2005 Catherine Trust"). As a result, the 623,458 shares beneficially owned by the Lux 2005 Catherine Trust are included in the aggregate indirect ownership of the reporting person. Accordingly, following these transactions Catherine Lux may be deemed to hold shared voting and dispositive power with respect to the 623,458 shares owned by the CNL Trust and the 14,731 shares owned by the Lux 2005 Catherine Trust. |
The Reporting Person may be deemed to be part of a group due to the entry by certain persons into a Shareholders Agreement dated April 1, 2021 as previously disclosed on the Reporting Person's Form 3/A filing with respect to MGPI dated October 7, 2021. The Reporting Person disclaims beneficial ownership of the shares of the Issuer's common stock reported herein, except to the extent of her pecuniary interest therein.